FBXO11 is mutated in lymphoid malignancies (13–15), required for normal hematopoiesis (16, 17), expressed at low levels in a subset of patients with AML (12), and implicated in regulating MHC class II expression in AML (18). The gene discussed is FBXO11; the disease is acute myeloid leukemia.